Serving the
Biotechnology and
Pharmaceutical
Industries
 
 
 

CEWorks™ , A New Analytic Application From ProSanos, Provides Rapid Performance Of Comparative Effectiveness Studies
(8/20/2010)

ProSanos Corporation is pleased to introduce CEWorks™, an innovative analytic software application providing comparative effectiveness data on demand for professionals in the life sciences and healthcare industries. CEWorks is part of the award winning suite of software products and services offered by ProSanos for pharmacovigilance, health outcomes, and the assessment of product effectiveness.

SĆfetyWorks® Captures Prestigious
Award at Industry Gathering in Boston (4/29/2009)

Harrisburg, PA – April 29, 2009. ProSanos Corporation is pleased to announce that SĆfetyWorks®, a web-based, semi-automated software system that helps scientists more quickly spot and measure the strength of associations between a drug and a medical condition found within large electronic healthcare databases, was recognized by Bio-IT World during the fifth annual Best Practices Awards program last evening in Boston MA.

ProSanos Corporation Releases New Software System to Improve Patient Safety Via Surveillance and Analysis of Claims and Electronic Health Records (8/12/2008)
ProSanos Corporation announced today the release of SĆfetyWorks®, a web-based, semi-automated software system that can help scientists more quickly spot and measure the strength of associations between a drug and a medical condition found within large electronic healthcare databases. SĆfetyWorks® resulted from a partnership between GlaxoSmithKline plc (GSK) and ProSanos. Several years in development, it is now available to all pharmacovigilance professionals.

ProSanos Corporation Announces the Release of CLĆRITY® for the Evaluation of Drug Safety (6/19/2007)
CLĆRITY® can be used to explore questions about the safety of a particular drug, class of drugs, or therapeutic area
Harrisburg, PA - June 19, 2007. ProSanos Corporation, specializing in the capture, integration, and analysis of healthcare-related data, has announced the launch of CLĆRITY, a next-generation software product that can be used to explore questions about the safety of a particular drug, class of drugs, or therapeutic area.

ProSanos VP of Research, Alan Hochberg, Appointed to Chair DIA SIAC (6/19/2007)
Alan Hochberg, ProSanos’ Vice President of Research was recently elected as the new North American chair for the Drug Information Association’s Statistics SIAC.

ProSanos Corporation Joins BioIT Alliance (11/14/2006)
ProSanos Corporation, specialists in the capture, integration, and analysis of healthcare-related data, is pleased to announce that it has joined Microsoft Corporation and an array of other leading organizations in a collaborative effort known as the BioIT Alliance.

Prosanos Corporation and France's Groupe MAPI Announce Strategic Partnership (7/26/2006)
ProSanos Corporation, specialists in the capture, integration, and analysis of healthcare-related data, and Groupe MAPI, an organization dedicated to providing the expertise needed to fully evaluate a drug’s properties and qualities, announce today the formation of a strategic corporate partnership which includes an investment in ProSanos by the MAPI Groupe.

ProSanos Corporation Awarded PhRMA Grant to Study Drug Safety (6/6/2006)
Sponsors Hope Effort to Bolster Monitoring and Detection of Adverse Events Will Lead to Improved Patient Outcomes and Enhanced Decision-Making for Drug Developers

ProSanos Receives Grant from the Department of Defense to Develop Pharmacovigilance Tool (1/24/2006)

ProSanos Selected as Central Penn Business Journal's Emerging Business of the Year for 2005 (12/7/2005)

ProSanos named #18 on list of 100 Fastest-Growing Private Companies (9/23/2005)

ProSanos named Rising Star of the Deloitte 2005 San Diego Technology Fast 50 (Two-time winner) (9/23/2005)

NCGR, Duke Medical Center, Henry Ford Hospital, Eli Lilly & Co., INCAPS, and ProSanos to develop diagnostic tests for sepsis and pneumonia (9/22/2005)

ProSanos Talks Safety Tools, Predicts New Controversy, with Bio IT (8/1/2005)

ProSanos Provides Case Study for Use of CDISC Operational Data Model (3/30/2005)
From the CDISC e-newsletter, a case study featuring ProSanos's use of the CDISC Operational Data Model (ODM)

ProSanos Named Finalist (2/8/2005)
ProSanos Corporation was named a finalist in the San Diego Business Journal “Best Companies To Work For in San Diego” contest.

ProSanos a Co-Founder of Standards Consortium (5/12/2004)

ProSanos SSEER Technology Powers New Registry (3/24/2004)

ProSanos® Receives Pennsylvania Greenhouse Investment (2/12/2004)

Myra Williams, Michael Lack Join ProSanos Board (12/2/2003)

ProSanos Establishes Central Pennsylvania Office; Wins Grant (4/29/2003)

ProSanos and Windber Research Institute to Collaborate (9/24/2002)

Second Roche Study Reports Protection Against Kidney Function Deterioration (8/30/2002)

New Meta-database Gives Kidney Researchers Valuable Tool (6/25/2002)

ProSanos Roche Study Shows Decreased Transplant Rejection (4/28/2002)

MSA, ProSanos™ Announce Strategic Alliance (6/21/2001)

LATEST NEWS

CEWorks™ , A New Analytic Application From ProSanos, Provides Rapid Performance Of Comparative Effectiveness Studies

Harrisburg, PA – August 20, 2010. ProSanos Corporation is pleased to introduce CEWorks™, an innovative analytic software application providing comparative effectiveness data on demand for professional...

More


The December 2009 OMOP Quarterly Newsletter is now available at omop.fnih.org

The Observational Medical Outcomes Partnership has released their December 2009 Newsletter. Topics include, among other things, a review of the 2009 OMOP Symposium held Nov. 12, 2009 in Bethesda, a d...

More


ProSanos featured in Insight Pharma Reports: Data Mining in Drug Development and Translational Medicine

...

More


If you'd like to receive email versions of news releases as ProSanos issues them, click here. Your contact information will be used solely for this purpose, and will not be shared with anyone outside ProSanos for any reason.